ArticleFrontiers in molecular biosciences2022
TRPM4 and TRPV2 are two novel prognostic biomarkers and promising targeted therapy in UVM.
Jiong Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it